Skip to content

A Randomized Controlled Study for Yuanhu Zhitong Dropping Pills in the Treatment of Knee Osteoarthritis

A Randomized Controlled Study for Yuanhu Zhitong Dropping Pills in the Treatment of Knee Osteoarthritis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002490
Enrollment
Unknown
Registered
2019-07-23
Start date
2019-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Sponsors

Gansu Institute of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) To meet the diagnostic criteria of knee osteoarthritis; (2) Aged 40 to 75 years; (3) Visual analogue scale (VAS) was greater than 10 mm and less than 60 mm. (4) According to the X-ray findings, the lesions included in the first stage, the second stage and the early stage of the third stage. (5) No medication has been taken in the past two weeks.

Exclusion criteria

Exclusion criteria: (1) Those who had received knee surgery in the past; (2) Patients with traumatic osteoarthritis; (3) Pregnant women and lactating women; (4) Those who are unable to attend the follow-up within one month; (5) Complicated with liver, kidney, hematopoietic system, digestive system, cardiovascular and cerebrovascular diseases and other serious primary diseases; (6) Patients with tuberculosis of knee joint, deformity of knee joint and malignant tumors of knee joint; (7) Those who suffer from psychiatric diseases and cannot participate in cooperation; (8) Those with history of opioid analgesics, sedatives and hypnotics and alcohol abuse; (9) those who have a history of allergy to experimental drugs

Design outcomes

Primary

MeasureTime frame
VAS score;

Countries

China

Contacts

Public ContactXie Xingwen

Gansu Institute of Traditional Chinese Medicine

827975272@qq.com+86 15002591615

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026